Search Results - "El-Khoueiry AB"

A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma.

Authors: El-Khoueiry AB Lieu CH Abou-Alfa GK et al.

Source: Liver cancer [Liver Cancer] 2026 Mar 30. Date of Electronic Publication: 2026 Mar 30.

Publication Type: Journal Article

Journal Info: Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101597993 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2235-1795 (Print) Linking ISSN: 16645553 NLM ISO Abbreviation: Liver Cancer

A multicenter dose-defining/expansion phase 1b study of first-line regorafenib plus pembrolizumab in patients with advanced hepatocellular carcinoma.

Authors: El-Khoueiry AB Kim RD Harris WP et al.

Source: Hepatology (Baltimore, Md.) [Hepatology] 2026 Jun 01; Vol. 83 (6), pp. 1433-1445. Date of Electronic Publication: 2025 Nov 10.

Publication Type: Journal Article; Clinical Trial, Phase I; Multicenter Study

Journal Info: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3350 (Electronic) Linking ISSN: 02709139 NLM ISO Abbreviation: Hepatology Subsets: MEDLINE

Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C-Mutated Tumors.

Authors: Dumbrava EE Shapiro GI Parikh AR et al.

Source: The New England journal of medicine [N Engl J Med] 2026 Feb 26; Vol. 394 (9), pp. 872-883.

Publication Type: Journal Article; Clinical Trial, Phase I; Multicenter Study

Journal Info: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancer.

Authors: Porter R Bockorny B Corr BR et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Dec 23; Vol. 13 (12). Date of Electronic Publication: 2025 Dec 23.

Publication Type: Journal Article; Clinical Trial, Phase I; Multicenter Study

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Assessing the Content and Quality of Online Patient Education Material on Clinical Trials From NCI-Designated Comprehensive Cancer Centers.

Authors: Beard TA Morales DL Arshaid A et al.

Source: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2025 Dec 18; Vol. 24 (1). Date of Electronic Publication: 2025 Dec 18.

Publication Type: Journal Article

Journal Info: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Electronic Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE

Radiomic signatures to estimate survival in patients with advanced hepatocellular carcinoma treated with sorafenib: Cancer and Leukemia Group B 80802 (Alliance).

Authors: Dercle L Geyer S Nixon AB et al.

Source: ESMO open [ESMO Open] 2025 Dec; Vol. 10 (12), pp. 105848. Date of Electronic Publication: 2025 Dec 02.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Safety and efficacy of intratumourally administered INT230-6 in adult patients with advanced solid tumours: results from an open-label phase 1/2 dose escalation study.

Authors: Thomas JS Siu LL Ingham M et al.

Source: EBioMedicine [EBioMedicine] 2025 Nov; Vol. 121, pp. 105980. Date of Electronic Publication: 2025 Oct 29.

Publication Type: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II

Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE

Exposure-response analysis for nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040).

Authors: Sangro B Yau T El-Khoueiry AB et al.

Source: Clinical and translational science [Clin Transl Sci] 2023 Aug; Vol. 16 (8), pp. 1445-1457. Date of Electronic Publication: 2023 May 30.

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE

Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas.

Authors: Wilky BA Schwartz GK Gordon MS et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Apr 10; Vol. 43 (11), pp. 1358-1368. Date of Electronic Publication: 2025 Jan 27.

Publication Type: Journal Article; Clinical Trial, Phase I; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Atezolizumab Plus Chemotherapy With or Without Bevacizumab in Advanced Biliary Tract Cancer: Clinical and Biomarker Data From the Randomized Phase II IMbrave151 Trial.

Authors: Macarulla T Ren Z Chon HJ et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Feb 10; Vol. 43 (5), pp. 545-557. Date of Electronic Publication: 2024 Oct 18.

Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).

Authors: Gholami S Colby S Horowitz DP et al.

Source: Annals of surgical oncology [Ann Surg Oncol] 2023 Mar; Vol. 30 (3), pp. 1354-1363. Date of Electronic Publication: 2023 Jan 09.

Publication Type: Clinical Trial; Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study.

Authors: Kudo M Ren Z Guo Y et al.

Corporate Authors: Kudo M Ren Z Guo Y et al.

Source: Lancet (London, England) [Lancet] 2025 Jan 18; Vol. 405 (10474), pp. 203-215. Date of Electronic Publication: 2025 Jan 08.

Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child-Pugh B liver function at study week 8: a retrospective analysis of the CELESTIAL randomised controlled trial.

Authors: El-Khoueiry AB Meyer T Cheng AL et al.

Source: BMC cancer [BMC Cancer] 2022 Apr 09; Vol. 22 (1), pp. 377. Date of Electronic Publication: 2022 Apr 09.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial.

Authors: Bullock AJ Schlechter BL Fakih MG et al.

Source: Nature medicine [Nat Med] 2024 Sep; Vol. 30 (9), pp. 2558-2567. Date of Electronic Publication: 2024 Jun 13.

Publication Type: Clinical Trial, Phase I; Journal Article

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Reply to the Letter to the Editor "Reflections on the statistical methodology in nivolumab and ipilimumab therapy research" by S. Yang.

Authors: Melero I Soleymani S Tschaika M et al.

Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Sep; Vol. 35 (9), pp. 827-828.

Publication Type: Letter

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma.

Authors: Rimassa L Kelley RK Meyer T et al.

Source: Liver cancer [Liver Cancer] 2021 Dec 03; Vol. 11 (1), pp. 38-47. Date of Electronic Publication: 2021 Dec 03 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101597993 Publication Model: eCollection Cited Medium: Print ISSN: 2235-1795 (Print) Linking ISSN: 16645553 NLM ISO Abbreviation: Liver Cancer Subsets: PubMed not MEDLINE

Improved efficacy of pembrolizumab combined with soluble EphB4-albumin in HPV-negative EphrinB2 positive head neck squamous cell carcinoma.

Authors: Jackovich A Gitlitz BJ Tiu-Lim JWW et al.

Source: Oncotarget [Oncotarget] 2024 Jul 10; Vol. 15, pp. 444-458. Date of Electronic Publication: 2024 Jul 10.

Publication Type: Journal Article; Clinical Trial, Phase II; Research Support, N.I.H., Extramural

Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Electronic Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040.

Authors: Melero I Yau T Kang YK et al.

Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Jun; Vol. 35 (6), pp. 537-548. Date of Electronic Publication: 2024 May 22.

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040.

Authors: El-Khoueiry AB Trojan J Meyer T et al.

Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Apr; Vol. 35 (4), pp. 381-391. Date of Electronic Publication: 2023 Dec 25.

Publication Type: Clinical Trial, Phase I; Journal Article

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma.

Authors: Abou-Alfa GK Geyer SM Nixon AB et al.

Source: Cancer research communications [Cancer Res Commun] 2024 Mar 07; Vol. 4 (3), pp. 682-690.

Publication Type: Clinical Trial, Phase III; Randomized Controlled Trial; Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE